Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01168323 · ClinicalTrials.gov registry record · NA

Spaced Education to Optimize Prostate Cancer Screening

A NA study, sponsored by Harvard University Faculty of Medicine.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT01168323: Completed NA study, sponsored by Harvard University Faculty of Medicine.

NCT01168323 is a NA study that has completed, run by Harvard University Faculty of Medicine. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01168323, a NA study, has completed, sponsored by Harvard University Faculty of Medicine.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

Two memory research findings (the spacing and testing effects) can dramatically improve retention of learning, but they have largely have been ignored by educators. The researchers have developed a novel form of online education (termed 'spaced education') based on these two effects which has been shown in randomized trials to improve knowledge acquisition and boost learning retention. Using prostate cancer screening as an experimental system, the researchers investigated whether spaced education could durably improve clinicians' behaviors, not just their knowledge.

Primary Outcome

The primary outcome measure was the difference in the percentage of inappropriate PSA screening performed by clinicians in the spaced education and control cohorts. Based on published clinical guidelines and reports, inappropriate PSA utilization was defined as the use of PSA for prostate cancer screening in patients \>76 or \<40 years old, or with an estimated life expectancy of less than 10 years.

Interventions

  • BEHAVIORAL Online spaced education

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2007-01
Est. Completion 2009-02
Phase NA

What the finished NCT01168323 record still lists

NCT01168323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Online spaced education is the first listed.

NCT01168323 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01168323 about?

NCT01168323 is a clinical study titled "Spaced Education to Optimize Prostate Cancer Screening". Two memory research findings (the spacing and testing effects) can dramatically improve retention of learning, but they have largely have been ignored by educators. The researchers have developed a novel form of online education (termed 'spaced education') based on these two effects which has been s...

What is the current status of trial NCT01168323?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2007-01. Estimated completion is 2009-02.

What interventions are being tested in trial NCT01168323?

The interventions under investigation include: Online spaced education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01168323?

This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01168323's enrollment target sits among peer trials

95 931st of 2000 higher than 1,066 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01168323, the US trial registry maintained by the National Library of Medicine. NCT01168323 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.